In the BioHarmony Drug Report Database

"Preview" Icon

Iloperidone

Fanapt (iloperidone) is a small molecule pharmaceutical. Iloperidone was first approved as Fanapt on 2009-05-06. It is used to treat schizophrenia and schizophrenia spectrum and other psychotic disorders in the USA. It is known to target 5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 1A, 5-hydroxytryptamine receptor 7, and D(2) dopamine receptor. Fanapt’s patents are valid until 2031-12-28 (FDA).

 

Trade Name

 

Fanapt
 

Common Name

 

iloperidone
 

ChEMBL ID

 

CHEMBL14376
 

Indication

 

schizophrenia, schizophrenia spectrum and other psychotic disorders
 

Drug Class

 

Antipsychotics (risperidone type)

Image (chem structure or protein)

Iloperidone structure rendering